In a report released on June 16, Puneet Souda from SVB Securities maintained a Buy rating on Bruker (BRKR – Research Report), with a price target of $92.00. The company’s shares closed last Friday at $75.48.
Souda covers the Healthcare sector, focusing on stocks such as NeoGenomics, Illumina, and Repligen. According to TipRanks, Souda has an average return of -7.2% and a 41.18% success rate on recommended stocks.
In addition to SVB Securities, Bruker also received a Buy from Bank of America Securities’s Derik De Bruin in a report issued on June 15. However, on June 16, J.P. Morgan maintained a Hold rating on Bruker (NASDAQ: BRKR).
See Insiders’ Hot Stocks on TipRanks >>
Based on Bruker’s latest earnings release for the quarter ending March 31, the company reported a quarterly revenue of $567.1 million and a net profit of $77.4 million. In comparison, last year the company earned a revenue of $595 million and had a net profit of $61.4 million
Based on the recent corporate insider activity of 29 insiders, corporate insider sentiment is negative on the stock. This means that over the past quarter there has been an increase of insiders selling their shares of BRKR in relation to earlier this year.
TipRanks has tracked 36,000 company insiders and found that a few of them are better than others when it comes to timing their transactions. See which 3 stocks are most likely to make moves following their insider activities.
Bruker Corp. engages in the development, manufacture, and distribution of scientific instruments, and analytical and diagnostic solutions that enable customers to explore life and materials at microscopic, molecular, and cellular levels. It operates through the Bruker Scientific Instruments (BSI), and Bruker Energy and Supercon Technologies (BEST) segments. The BSI segment comprises of the Bruker BioSpin Group, the Bruker CALID Group, and the Bruker Nano Group. The BEST segment designs, manufactures, and distributes superconducting materials, primarily metallic low temperature superconductors, for use in magnetic resonance imaging, nuclear magnetic resonance, fusion energy research and other applications. The company was founded by Gunther Laukien in 1961 and is headquartered in Billerica, MA.
Read More on BRKR:
